Ziegler Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $7.85M | Buy |
82,173
+3,668
| +5% | +$351K | 0.3% | 110 |
|
|
2023
Q4 | $5.99M | Sell |
78,505
-6,075
| -7% | -$463K | 0.27% | 87 |
|
|
2023
Q3 | $5.86M | Sell |
84,580
-3,350
| -4% | -$232K | 0.23% | 150 |
|
|
2023
Q2 | $8.29M | Sell |
87,930
-1,419
| -2% | -$134K | 0.32% | 118 |
|
|
2023
Q1 | $7.39M | Buy |
89,349
+2,365
| +3% | +$196K | 0.29% | 130 |
|
|
2022
Q4 | $6.49M | Sell |
86,984
-5,895
| -6% | -$440K | 0.27% | 135 |
|
|
2022
Q3 | $7.67M | Sell |
92,879
-27,033
| -23% | -$2.23M | 0.34% | 104 |
|
|
2022
Q2 | $11.4M | Buy |
119,912
+72,052
| +151% | +$6.85M | 0.47% | 63 |
|
|
2022
Q1 | $5.64M | Buy |
47,860
+3,103
| +7% | +$366K | 0.24% | 146 |
|
|
2021
Q4 | $5.8M | Sell |
44,757
-2,494
| -5% | -$323K | 0.21% | 163 |
|
|
2021
Q3 | $5.34M | Buy |
47,251
+39,516
| +511% | +$4.47M | 0.19% | 174 |
|
|
2021
Q2 | $6.75M | Sell |
7,735
-56,910
| -88% | -$49.7M | 0.23% | 161 |
|
|
2021
Q1 | $5.41M | Buy |
64,645
+552
| +0.9% | +$46.2K | 0.17% | 192 |
|
|
2020
Q4 | $5.85M | Sell |
64,093
-1,615
| -2% | -$147K | 0.19% | 178 |
|
|
2020
Q3 | $5.24M | Sell |
65,708
-225,849
| -77% | -$18M | 0.2% | 179 |
|
|
2020
Q2 | $20.2M | Sell |
291,557
-46,828
| -14% | -$3.24M | 0.64% | 33 |
|
|
2020
Q1 | $25.8M | Buy |
+338,385
| New | +$25.8M | 0.69% | 28 |
|